Neurology

publication venue for

Teaching NeuroImage: Hemorrhagic Arachnoid Cyst. 2024
Clinical Reasoning: Patient With Prior Spinal Cord Injury Who Developed Altered Mental Status After a Fall. 2022
Intracranial optic nerve enlargement in infantile Krabbe disease. 2012
Hemangioma of the cavernous sinus in a child. 2011
Isolated oculomotor palsy following minor head trauma. 2005
Brachial plexopathy associated with human granulocytic ehrlichiosis. 1996
Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity. 1994
Tropical spastic paraparesis in the Seychelles Islands: a clinical and case-control neuroepidemiologic study. 1987
Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions.. 103. 2024
Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility.. 102. 2024
Palatal Myoclonus Due to Cortical Cavernous Malformation.. 102. 2024
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort.. 102. 2024
Radon Exposure, Clonal Hematopoiesis, and Stroke Susceptibility in the Women's Health Initiative.. 102. 2024
Breastfeeding and Mothers With Epilepsy.. 101. 2023
Aneurysms: Should We Screen Everyone Who Has a Family History of This?. 101. 2023
Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children. 2023
Migraine and Hormones: A Complex Interaction.. 100. 2023
Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer.. 100. 2023
Association of Brain Age, Lesion Volume, and Functional Outcome in Patients With Stroke. 2023
A Focus on Subtle Signs and Motor Behavior to Unveil Awareness in Unresponsive Brain-Impaired Patients: The Importance of Being Clinical. 2023
The Risk of a Second Stroke: Does Race Play a Role?. 99. 2022
The State of Inpatient Child Neurology: A Survey of North American Academic Programs.. 99. 2022
Seizure Detection and Wearables: Integrating Technology in Patient Care.. 99. 2022
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. 2022
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series.. 99. 2022
Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study.. 99. 2022
Ethics and the 2018 Practice Guideline on Disorders of Consciousness: A Framework for Responsible Implementation. 2022
Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials. 2021
Treating Stroke From Inside the Blood Vessel: Time Matters.. 97. 2021
Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife. 2021
Alzheimer Disease and Mood.. 97. 2021
Contemporary Neuroscience Core Curriculum for Medical Schools. 2021
Emerging Subspecialties in Neurology: Becoming an Editor-in-Chief. 2021
Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update.. 97. 2021
Myasthenia Gravis: Which Type of Surgery Is Best?. 97. 2021
Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort. 2021
RCVS: Symptoms, Incidence, and Resource Utilization in a Population-Based US Cohort. 2021
Silent Myocardial Infarction and Subsequent Ischemic Stroke in the Cardiovascular Health Study.. 97. 2021
Education Research: NeuroBytes: A New Rapid, High-Yield e-Learning Platform for Continuing Professional Development in Neurology.. 97. 2021
After a Stroke: How Quickly Should Exercise Begin?. 96. 2021
Prevalence of Cervical Artery Dissection Among Hospitalized Patients With Stroke by Age in a Nationally Representative Sample From the United States.. 96. 2021
Neurologic Syndromes Predict Higher In-Hospital Mortality in COVID-19.. 96. 2020
Racial Differences in Atrial Cardiopathy Phenotypes in Ischemic Stroke Patients. 2020
Quality improvement in neurology: Headache Quality Measurement Set.. 95. 2020
Cause of death in spontaneous intracerebral hemorrhage survivors: Multistate longitudinal study.. 95. 2020
Cardiac phenotype in ATP1A3-related syndromes: A multicenter cohort study.. 95. 2020
Association of race and ethnicity to incident epilepsy, or epileptogenesis, after subdural hematoma.. 95. 2020
Apolipoprotein E genotype and in vivo amyloid burden in middle-aged Hispanics.. 95. 2020
Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial.. 95. 2020
Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.. 95. 2020
Antihyperthermic treatment decreases perihematomal hypodensity.. 94. 2020
Understanding the different types of ALS.. 94. 2020
Racial/ethnic disparities in the risk of intracerebral hemorrhage recurrence.. 94. 2019
Low hemoglobin and hematoma expansion after intracerebral hemorrhage.. 93. 2019
Current state of educational compensation in academic neurology: Results of a US national survey.. 93. 2019
Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.. 92. 2019
Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage.. 92. 2019
Core curriculum guidelines for a required clinical neurology experience.. 92. 2019
Effect of aerobic exercise on cognition in younger adults: A randomized clinical trial.. 92. 2019
Teaching NeuroImages: Facial swelling and intracerebral hemorrhage from venous hypertension in a dialysis patient.. 92. 2019
Neurologic and neuroscience education: Mitigating neurophobia to mentor health care providers.. 92. 2018
Pregnancy, anti-seizure medications, and seizures.. 91. 2018
A dozen years of evolution of neurology clerkships in the United States: Looking up.. 91. 2018
Incorporating sleep medicine content into medical school through neuroscience core curricula.. 91. 2018
Left atrial diameter and vascular brain injury on MRI: The Cardiovascular Health Study.. 91. 2018
Does epilepsy increase the risk of needing to return to the hospital due to mood disorders?. 91. 2018
Increased risk of hospital admission for mood disorders following admission for epilepsy.. 91. 2018
New diagnosis of cancer and the risk of subsequent cerebrovascular events.. 90. 2018
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.. 90. 2018
Epilepsy and risk of injury.. 90. 2018
Multiple pathways of reserve simultaneously present in cognitively normal older adults.. 90. 2017
Quality improvement in neurology: Child neurology quality measure set: Executive summary.. 90. 2017
Long-term risk of seizures in adult survivors of sepsis.. 89. 2017
Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. 89. 2017
Penfield's ceiling: Seeing brain injury through Galen's eyes.. 89. 2017
Association of parathyroid hormone with 20-year cognitive decline: The ARIC study.. 89. 2017
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. 89. 2017
Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.. 88. 2017
Predicting growth of brain aneurysms.. 88. 2017
Outcomes after intracerebral hemorrhage from arteriovenous malformations.. 88. 2017
A dedicated scholarly research program in an adult and pediatric neurology residency program.. 88. 2017
Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.. 87. 2016
Gray matter maturation and cognition in children with different APOE ε genotypes.. 87. 2016
Advanced interatrial block and ischemic stroke: The Atherosclerosis Risk in Communities Study.. 87. 2016
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.. 87. 2016
Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.. 85. 2015
Mediterranean diet and brain structure in a multiethnic elderly cohort.. 85. 2015
Predicting frequent ED use by people with epilepsy with health information exchange data.. 85. 2015
Recurrent stroke in childhood cancer survivors.. 85. 2015
Acute headache diagnosis in pregnant women: a hospital-based study.. 85. 2015
Stroke subtype and motor impairment influence contralesional excitability.. 85. 2015
Temporal relationship between infective endocarditis and stroke.. 85. 2015
Seizure localization using ictal phase-locked high gamma: A retrospective surgical outcome study.. 84. 2015
Sleep-disordered breathing advances cognitive decline in the elderly.. 84. 2015
HIV status and the risk of ischemic stroke among men.. 84. 2015
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy.. 84. 2015
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.. 84. 2014
Status of neurology medical school education: results of 2005 and 2012 clerkship director survey.. 83. 2014
APOE polymorphisms and cognitive functions in patients with brain tumors.. 83. 2014
Recurrent thromboembolic events after ischemic stroke in patients with cancer.. 83. 2014
Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH.. 82. 2014
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.. 82. 2014
Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.. 82. 2014
Abnormal metabolic network activity in REM sleep behavior disorder.. 82. 2014
Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.. 82. 2014
Recommendations for imaging tumor response in neurofibromatosis clinical trials.. 81. 2013
Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.. 81. 2013
Lack of association between autism and anti-GM1 ganglioside antibody.. 81. 2013
Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome.. 81. 2013
Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk.. 80. 2013
Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study.. 80. 2013
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors.. 80. 2013
Education Research: can my electronic health record teach me something?: A multi-institutional pilot study.. 80. 2013
Septal nuclei enlargement in human temporal lobe epilepsy without mesial temporal sclerosis.. 80. 2013
Metabolic changes in DYT11 myoclonus-dystonia.. 80. 2013
Generalized periodic discharges in the critically ill: a case-control study of 200 patients.. 79. 2012
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation.. 79. 2012
Racial differences in albuminuria, kidney function, and risk of stroke.. 79. 2012
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.. 79. 2012
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.. 79. 2012
Inpatient statin use predicts improved ischemic stroke discharge disposition.. 78. 2012
Location-weighted CTP analysis predicts early motor improvement in stroke: a preliminary study.. 78. 2012
Network correlates of disease severity in multiple system atrophy.. 78. 2012
Peripheral nerve inflammation in ALS mice: cause or consequence.. 78. 2012
Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.. 78. 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkers.. 78. 2012
Memory after silent stroke: hippocampus and infarcts both matter.. 78. 2012
Arterial spin labeling and altered cerebral blood flow patterns in the minimally conscious state.. 77. 2011
A randomized trial of hypothesis-driven vs screening neurologic examination.. 77. 2011
Network correlates of the cognitive response to levodopa in Parkinson disease.. 77. 2011
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.. 77. 2011
Patient-ventilator asynchrony with nocturnal noninvasive ventilation in ALS.. 77. 2011
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma.. 76. 2011
Charles Marcel Poser, MD, FAAN (1923–2010).. 76. 2011
Emerging subspecialties in neurology: neurophysiologic intraoperative monitoring.. 76. 2011
Patient page. Driving after a stroke.. 76. 2011
Abnormal metabolic brain networks in Tourette syndrome.. 76. 2011
Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.. 76. 2011
Effectiveness of a modified Continuum curriculum for medical students: a randomized trial.. 76. 2011
A network approach to assessing cognition in disorders of consciousness.. 75. 2010
Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects.. 75. 2010
HIV/AIDS and neurologic diseases.. 75. 2010
HLA B*44: protective effects in MS susceptibility and MRI outcome measures.. 75. 2010
Biallelic TSC gene inactivation in tuberous sclerosis complex.. 74. 2010
Leptomeningeal metastases in the MRI era.. 74. 2010
Clinical and prognostic subforms of new daily-persistent headache.. 74. 2010
Migraine and cardiovascular disease: a population-based study.. 74. 2010
Intracerebral and subarachnoid hemorrhage in patients with cancer.. 74. 2010
Bevacizumab for recurrent ependymoma.. 73. 2009
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.. 73. 2009
Patient page. Juvenile myoclonic epilepsy, a common epilepsy syndrome.. 73. 2009
Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.. 72. 2009
Predictors of individual visual memory decline after unilateral anterior temporal lobe resection.. 72. 2009
SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy.. 72. 2009
Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS.. 72. 2009
Using botulinum toxin to treat diabetic foot pain.. 72. 2009
Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study.. 72. 2009
Patient page. Progressive supranuclear palsy.. 71. 2008
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.. 71. 2008
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.. 72. 2008
Right Brain: and I saw a brain die.. 71. 2008
Intensive nutritional supplements can improve outcomes in stroke rehabilitation.. 71. 2008
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.. 71. 2008
Patient page. Epilepsy and pregnancy: are seizure medications safe?. 71. 2008
Patient page. Gene therapy and muscular dystrophies.. 71. 2008
Ischemic stroke in patients with primary brain tumors.. 70. 2008
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.. 70. 2008
Bacterial and fungal meningitis in patients with cancer.. 70. 2008
Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.. 70. 2008
A structural basis for reading fluency: white matter defects in a genetic brain malformation.. 69. 2007
Randomized trial of IV dexamethasone for acute migraine in the emergency department.. 69. 2007
Cognitive impairment in familial ALS.. 69. 2007
Electrographic seizures and periodic discharges after intracerebral hemorrhage.. 69. 2007
Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.. 69. 2007
Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.. 69. 2007
Phase II/III randomized trial of TCH346 in patients with ALS.. 69. 2007
Blood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study.. 69. 2007
Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.. 69. 2007
Predicting short-term disability in multiple sclerosis.. 68. 2007
How migraines affect cognitive function.. 68. 2007
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.. 68. 2007
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.. 68. 2007
Late recovery from the minimally conscious state: ethical and policy implications.. 68. 2007
Retinopathy in survivors of primary central nervous system lymphoma.. 67. 2006
The value of database controls in pilot or futility studies in ALS.. 67. 2006
The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.. 67. 2006
High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial.. 67. 2006
Quality improvement in acute stroke: the New York State Stroke Center Designation Project.. 67. 2006
Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients.. 66. 2006
Thrombolytic therapy of acute ischemic stroke during pregnancy.. 66. 2006
Identification of potential CSF biomarkers in ALS.. 66. 2006
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.. 66. 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.. 66. 2006
Results of intervention for lupus patients with self-perceived cognitive difficulties.. 65. 2005
Limitations of Wada memory asymmetry as a predictor of outcomes after temporal lobectomy.. 65. 2005
Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.. 65. 2005
Prevalence and patterns of cognitive impairment in sporadic ALS.. 65. 2005
Electrical impedance myography in the bedside assessment of inflammatory myopathy.. 65. 2005
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.. 64. 2005
Heads down: flat positioning improves blood flow velocity in acute ischemic stroke.. 64. 2005
fMRI reveals large-scale network activation in minimally conscious patients.. 64. 2005
Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation.. 64. 2005
Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.. 64. 2005
Atrophy rate in medial temporal lobe during progression of Alzheimer disease.. 63. 2004
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.. 63. 2004
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.. 63. 2004
Season of birth and risk of brain tumors in adults.. 63. 2004
Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden.. 62. 2004
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS).. 62. 2004
The metabolic topography of posthypoxic myoclonus.. 62. 2004
HFE mutations are not strongly associated with sporadic ALS.. 62. 2004
Cerebral lactic acidosis correlates with neurological impairment in MELAS.. 62. 2004
Regional metabolism in primary torsion dystonia: effects of penetrance and genotype.. 62. 2004
Neuropsychiatric impact of hepatitis C on advanced HIV.. 62. 2004
Cognitive functions in survivors of primary central nervous system lymphoma.. 62. 2004
Widespread increased expression of the DNA repair enzyme PARP in brain in ALS.. 62. 2004
Brain metabolic differences between sporadic and familial Alzheimer's disease.. 61. 2003
Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.. 61. 2003
CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.. 61. 2003
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.. 61. 2003
Seizure frequency is associated with age at menopause in women with epilepsy.. 61. 2003
Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study.. 60. 2003
Effects of levodopa on motor sequence learning in Parkinson's disease.. 60. 2003
Anti-ganglioside antibodies in idiopathic and hereditary cerebellar degeneration.. 60. 2003
The differential effect of PD and normal aging on early explicit sequence learning.. 60. 2003
Enhancement of brain activation during trial-and-error sequence learning in early PD.. 60. 2003
Primary CNS lymphoma: a whole-brain disease?. 59. 2002
Antiepileptic drug use during the first 12 months of vagus nerve stimulation therapy: a registry study.. 59. 2002
Effects of levodopa infusion on motor activation responses in Parkinson's disease.. 59. 2002
Donepezil and flight simulator performance: effects on retention of complex skills.. 59. 2002
Predictors of functional disability and mortality after status epilepticus.. 58. 2002
Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans.. 57. 2001
Metabolic correlates of levodopa response in Parkinson's disease.. 57. 2001
Immune reactivity in a mouse model of familial ALS correlates with disease progression.. 57. 2001
In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy.. 57. 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy.. 57. 2001
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.. 57. 2001
Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study.. 57. 2001
Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome.. 56. 2001
A pilot study of drug-induced hypertension for treatment of acute stroke.. 56. 2001
Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease.. 56. 2001
A surface plasmon resonance biosensor assay for measurement of anti-GM(1) antibodies in neuropathy.. 56. 2001
Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia.. 56. 2001
Stroke as a complication of cardiac catheterization: risk factors and clinical features.. 56. 2001
Management of multiple sclerosis across managed care and fee-for-service systems.. 55. 2000
Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease.. 55. 2000
The metabolic topography of essential blepharospasm: a focal dystonia with general implications.. 55. 2000
Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology.. 55. 2000
Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates.. 54. 2000
Long-term outcome of low-grade oligodendroglioma and mixed glioma.. 54. 2000
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.. 54. 2000
Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera.. 54. 2000
Antiphosphatidyl serine antibodies are independently associated with ischemic stroke.. 53. 1999
General neurologist and subspecialist care for multiple sclerosis: patients' perceptions.. 53. 1999
Differences in the gyral pattern distinguish chromosome 17-linked and X-linked lissencephaly.. 53. 1999
End-of-life care: a survey of US neurologists' attitudes, behavior, and knowledge.. 53. 1999
Hemispheric asymmetries in arousal affect outcome of the intracarotid amobarbital test.. 52. 1999
Primary intracranial neoplasms in patients with HIV.. 52. 1999
A DLST genotype associated with reduced risk for Alzheimer's disease.. 52. 1999
The effect of estrogen replacement on early Parkinson's disease.. 52. 1999
Herpes varicella zoster encephalitis in immunocompromised patients.. 52. 1999
Adult brainstem gliomas.. 51. 1998
CADASIL in a North American family: clinical, pathologic, and radiologic findings.. 51. 1998
The metabolic anatomy of tremor in Parkinson's disease.. 51. 1998
Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.. 50. 1998
Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later.. 50. 1998
111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.. 50. 1998
Assessment of motor function after stereotactic pallidotomy.. 50. 1998
Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.. 49. 1997
Assessment: dermatomal somatosensory evoked potentials. Report of the American Academy of Neurology's Therapeutics and Technology Assessments Subcommittee.. 49. 1997
Preoperative indicators of clinical outcome following stereotaxic pallidotomy.. 49. 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.. 49. 1997
Increased CSF glutamate following injection of ALS immunoglobulins.. 48. 1997
Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation.. 48. 1997
Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy.. 48. 1997
Steroid myopathy in cancer patients.. 48. 1997
The metabolic anatomy of Tourette's syndrome.. 48. 1997
Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations.. 47. 1996
Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group.. 47. 1996
Complications of intravenous immune globulin treatment in neurologic disease.. 47. 1996
Hippocampal formation size predicts declining memory performance in normal aging.. 47. 1996
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Sträussler-Scheinker disease (PrP-P102L mutation).. 47. 1996
Motor neuropathy due to docetaxel and paclitaxel.. 47. 1996
The effect of spectrum bias on the utility of magnetic resonance imaging and evoked potentials in the diagnosis of suspected multiple sclerosis.. 47. 1996
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma.. 46. 1996
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).. 46. 1996
Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy.. 46. 1996
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.. 46. 1996
Horner's syndrome after coronary artery bypass surgery.. 46. 1996
Low-grade oligodendroglioma responds to chemotherapy.. 46. 1996
Cerebral metabolic topography in unilateral temporal lobe epilepsy.. 45. 1995
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.. 45. 1995
Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line.. 45. 1995
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.. 45. 1995
Stereotactic ventral pallidotomy for Parkinson's disease.. 45. 1995
Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry.. 45. 1995
Epidemic neuropathy in Cuba: a plea to end the United States economic embargo on a humanitarian basis.. 44. 1994
Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS.. 44. 1994
Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers.. 44. 1994
Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage.. 44. 1994
Assessment: melodic intonation therapy. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.. 44. 1994
Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy.. 43. 1993
Complications of therapy for venous thromboembolic disease in patients with brain tumors.. 43. 1993
Hyperkalemic periodic paralysis: rapid molecular diagnosis and relationship of genotype to phenotype in 12 families.. 43. 1993
Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve.. 43. 1993
Motor neuron diseases and amyotrophic lateral sclerosis: GM1 antibodies and paraproteinemia.. 43. 1993
Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins.. 42. 1992
Amphotericin B-associated leukoencephalopathy.. 42. 1992
Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.. 42. 1992
Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.. 42. 1992
Electrophysiologic changes in lumbar spinal cord after cervical cord injury.. 42. 1992
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?. 42. 1992
Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.. 41. 1991
Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy.. 41. 1991
Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome.. 41. 1991
Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations.. 41. 1991
Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis.. 41. 1991
A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis.. 41. 1991
Roy and Sherrington (1890): a centennial reexamination of "On the regulation of the blood-supply of the brain".. 41. 1991
Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.. 40. 1990
The spectrum of neurologic disease associated with anti-GM1 antibodies.. 40. 1990
Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter.. 40. 1990
Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes.. 40. 1990
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.. 40. 1990
The role of radiation therapy following resection of single brain metastasis from melanoma.. 40. 1990
Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M proteins and neuropathy.. 39. 1989
Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord.. 39. 1989
Radiation-induced dementia in patients cured of brain metastases.. 39. 1989
Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.. 38. 1988
Atherosclerotic carotid artery disease in patients with retinal ischemic syndromes.. 38. 1988
MRI demonstrates descending transtentorial herniation.. 38. 1988
Seronegative myasthenia gravis.. 38. 1988
State-dependent changes in the N20 component of the median nerve somatosensory evoked potential.. 38. 1988
Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein.. 37. 1987
Motor neuron disease and plasma cell dyscrasia.. 36. 1986
Positron emission tomography in Alzheimer's disease.. 36. 1986
Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiency.. 36. 1986
Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease.. 36. 1986
Effect of cervical spinal cord lesions on early components of the median nerve somatosensory evoked potential.. 36. 1986
Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins.. 35. 1985
The neuropathy of plasma cell dyscrasia: binding of IgM M-proteins to peripheral nerve glycolipids.. 35. 1985
Axonal neuropathy in a patient with IgM M-protein reactive with nerve endoneurium.. 35. 1985
Anti-MAG antibody and antibody complexes: detection by radioimmunoassay.. 35. 1985
Specificity of mouse and human monoclonal antibodies to myelin-associated glycoprotein.. 34. 1984
Experimental demyelination produced by the A59 strain of mouse hepatitis virus.. 34. 1984
Anti-MAG IgM antibodies in patients with neuropathy and IgM M proteins: detection by ELISA.. 33. 1983
Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia.. 32. 1982
Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia.. 31. 1981
Brachial plexus lesions in patients with cancer: 100 cases.. 31. 1981
Duration of apnea needed to confirm brain death.. 28. 1978
Does pseudotumor cerebri cause the empty sella syndrome?. 25. 1975
Carbohydrate metabolism of synapses.. 20. 1970
The effects of electrically induced seizures on potassium transport within isolated nerve terminals.. 20. 1970
Synapse function in vitro.. 18. 1968
INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY.. 14. 1964
Comment: Time for neurologists to see visual snow.. 93. 2019
Author response: Ethical, palliative, and policy considerations in disorders of consciousness.. 92. 2019
Multiple sclerosis, inflammation in the brain, and mood.. 89. 2017
Comment: Headache medicine as an emerging subspecialty-Irony and reality.. 88. 2017
Using stem cells to treat ALS.. 87. 2016
Teaching NeuroImages: Neurocutaneous melanosis.. 85. 2015
Diagnosis and treatment of facioscapulohumeral muscular dystrophy: 2015 guidelines.. 85. 2015
Brain cell injury in HIV infection: when does it start and can it be stopped?. 83. 2014
Taking epilepsy medications consistently: why it makes a difference.. 82. 2014
Alzheimer disease: which test is best?. 81. 2013
Temporal lobe epilepsy surgery: what is the best approach?. 80. 2013
Neural anomaly and reorganization in speakers who stutter: A short-term intervention study.. 80. 2013
Trigeminal nerve stimulator: a new treatment for seizures?. 80. 2013
Psychogenic dystonia and peripheral trauma.. 77. 2011
Patient page. Concussion.. 76. 2011
Corpus callosum dysgenesis limits MRI changes to one hemisphere in status epilepticus.. 73. 2009
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.. 73. 2009
Neuromyelitis optica.. 72. 2009
Early Parkinson disease and depression.. 69. 2007
The portrayal of coma in contemporary motion pictures.. 68. 2007
No evidence for heritability of Parkinson disease in Swedish twins.. 64. 2005
Neuropsychiatric impact of hepatitis C on advanced HIV.. 64. 2005
Cerebral lactic acidosis correlates with neurological impairment in MELAS.. 63. 2004
CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.. 62. 2004
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.. 62. 2004
Donepezil and flight simulator performance: effects on retention of complex skills.. 61. 2003
The minimally conscious state: definition and diagnostic criteria.. 59. 2002
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.. 56. 2001
Bismuth toxicity.. 44. 1994
Denervation in paraplegia.. 42. 1992
Periventricular hyperintensity.. 42. 1992
Colored hearing synesthesia.. 39. 1989
Amitriptyline in Alzheimer's disease.. 33. 1983
Rapid capsule wall formation.. 28. 1978
Reader Response: Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study. 2023
Epilepsy and Depression: How Are They Related? 2023
Reader Response: Determination of Death by Neurologic Criteria Around the World. 2021
Reader Response: Prediction of Regaining Consciousness Despite an Early Epileptiform EEG After Cardiac Arrest. 2021
Reader response: Reducing birth defects in women with epilepsy: Research leading to results. 2020
Reader response: Acute elevation of serum inflammatory markers predicts symptom recovery after concussion. 2020
Reader response: New onset refractory status epilepticus research: What is on the horizon? 2020
Reader response: Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US. 2020
Reader response: Value of witness observations in the differential diagnosis of transient loss of consciousness. 2020
Reader response: Variability in reported physician practices for brain death determination. 2020
Reader response: Adherence with psychotherapy and treatment outcomes for psychogenic nonepileptic seizures. 2019
Reader response: Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement. 2019
Reader response: Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients. 2019
Reader response: Sleep-disordered breathing among patients admitted for inpatient video-EEG monitoring. 2019
Reader response: Concussion serum biomarkers: A quest for the Holy Grail? 2019
Reader response: Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment. 2019
Reader response: Incorporating sleep medicine content into medical school through neuroscience core curricula. 2019
Reader response: To harvest?: A reality-based ethical dilemma and fictional dialogue. 2019
Reader response: Ethical, palliative, and policy considerations in disorders of consciousness. 2019
Exercise: Can this help to improve or preserve cognitive function throughout adulthood? 2019
Reader response: Outcome after seizure recurrence on antiepileptic drug withdrawal following temporal lobectomy. 2019
Reader response: Financial relationships between neurologists and industry: The 2015 Open Payments database. 2019
Reader response: Right Brain: Withholding treatment from a child with an epileptic encephalomyopathy. 2019
Reader response: Education research: The current state of neurophysiology education in selected neurology residency programs. 2018
Reader response: Behavioral interventions as a treatment for epilepsy: A multicenter randomized controlled trial. 2018
Reader response: An interdisciplinary response to contemporary concerns about brain death determination. 2018
Reader response: Residency training: The need for an integrated diversity curriculum for neurology residency. 2018
Reader response: Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016. 2018
Reader response: Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016. 2018
Journal Club: Pregnancy outcome following maternal exposure to pregabalin may call for concern. 2017
Advanced interatrial block and ischemic stroke: The Atherosclerosis Risk In Communities Study. 2016
The head trauma amnesia cure: The making of a medical myth. 2016
Standardized EEG interpretation accurately predicts prognosis after cardiac arrest. 2016
Author Response. 2016
Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. 2015
Association of prone position with sudden unexpected death in epilepsy. 2015
Physician burnout: A neurologic crisis. 2015
Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis. 2015
Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis. 2015
Reforms in academic neurology: needs of a rapidly changing India. 2014
International electives in neurology training: A survey of US and Canadian program directors. 2014
Meeting the challenges of stroke in India. 2014
Meeting the challenges of stroke in India. 2014
Ethical and quality pitfalls in electronic health records. 2013
Lamotrigine and aseptic meningitis. 2012
An unusual cause of isolated vomiting. 2012
Generic antiepileptic drugs and associated medical resource utilization in the United States. 2011
Leptomeningeal metastases in the MRI era. 2011
Psychogenic nonepileptic "seizures " or "attacks"? It's not just semantics: attacks: psychogenic nonepileptic "seizures" or "attacks"? It's not just semantics: seizures. 2010
The pervasive influence of conflicts of interest: a personal perspective. 2010
Enhanced QT shortening and persistent tachycardia after generalized seizures. 2010
The risks and costs of multiple-generic substitution of topiramate. 2010
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial: botulinum toxin for neuropathic pain? 2010
Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. 2009
Training in neurology. 2009
Re: Electrographic seizures and periodic discharges after intracerebral hemorrhage. 2008
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. 2007
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. 2005
Differentiation of vascular dementia from AD on neuropsychological tests. 2000
111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. 1999
Steroid myopathy in cancer patients. 1998
Radiotherapy at tumor recurrence in primary CNS lymphoma. 1998
Complications of intravenous immune globulin treatment in neurologic disease. 1997
Docetaxel neuropathy. 1996
Cuban optic neuropathy. 1995
Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology. 2005
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. 1993
Millions of Migraine Attacks, Many Answers, More Questions. 2023
Finding Fellowship In Neurology Fellowship Recruitment. 2022
Visual snow: Are we beginning to see the light?. 94. 2020
Predicting large vessel occlusion with a clinical scale: Building a better mousetrap.. 93. 2019
Atrial cardiopathy: A new cause for stroke?. 92. 2018
Medication overuse headache: An ongoing debate.. 89. 2017
Hastened death in ALS: Damaged brains and bad decisions?. 87. 2016
Imaging and rare APOE alleles: Alzheimer disease as a developmental disorder.. 87. 2016
Understanding the comparative effectiveness of treatment in pediatric epilepsy: Call to action.. 84. 2015
Functional imaging to uncover willful brain behavior in noncommunicative patients.. 84. 2014
Hypertensive crisis: Reversible edema in leukoencephalopathy, retinopathy, now myelopathy?. 83. 2014
rtPA in acute stroke patients with history of cognitive impairment: do not hesitate to treat.. 82. 2014
Attention following stroke.. 81. 2013
Different β-amyloid binding patterns in Alzheimer and Parkinson diseases: it's the network!. 81. 2013
Optic nerve head component analysis enters the clinic: will multifocal ERG be the next OCT?. 81. 2013
Blurring of local and remote practice models threatens IOM's future.. 80. 2013
Higher macular volume in patients with MS receiving fingolimod: positive outcome or side effect?. 80. 2012
Preconditioning reaches clinical practice in intracranial arterial stenosis.. 79. 2012
Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62: a functional convergence?. 79. 2012
To scan or not to scan: DaT is the question.. 78. 2012
Targeting sleep disruption using sodium oxybate in chronic cluster headache prophylaxis.. 77. 2011
Cerebral small-vessel disease: what lies beyond the early years?. 76. 2011
Why do we respond differently to sleep deprivation?: it's in our genes!. 75. 2010
Mom and me: brain metabolism links Alzheimer disease to maternal genes.. 72. 2009
Chemotherapy for low-grade gliomas: emerging consensus on its benefits.. 68. 2007
Testing a test for Alzheimer disease.. 68. 2007
Can imaging distinguish PSP from other neurodegenerative disorders?. 58. 2002
A better way to find tumor in the CSF?. 58. 2002
Do stutterers have different brains?. 57. 2001
Weighing the benefits and risks of radiation therapy for low-grade glioma.. 56. 2001
Disease, drugs, decisions, and dollars.. 52. 1999
Brain tumor therapy: new horizons, new hope.. 50. 1998
Primary central nervous system lymphoma: a new clinical challenge.. 41. 1991
The Effects of Long-term Medication Use in Alzheimer Disease. 2021
Does deep brain stimulation help early or mild Parkinson disease? 2018
Orientation to person, orientation to self. 2015
Imaging markers for Alzheimer disease: which vs how. 2013
MRI findings in Susac's syndrome. 2003
Diagnosis of CIDP. 2002
Autoimmunity and ALS. 1996
X-linked malformations of neuronal migration. 1996
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. 1992
Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source: A Meta-Analysis of Randomized Controlled Trials. 2024
Implications of Large Language Models for Quality and Efficiency of Neurologic Care: Emerging Issues in Neurology. 2024
Biomarkers in Alzheimer Disease: A Review. 2023
Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. 2020
Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. 2015
Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosis. 2004
Stroke in patients with cancer: incidence and etiology. 2004
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. 2004
Challenges in the design and conduct of phase III brain tumor therapy trials. 1997
Does a long preclinical period occur in Parkinson's disease? 1991
Multiple sclerosis or HTLV-I myelitis? 1990
Tropical myeloneuropathies: the hidden endemias. 1985
Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. 1994

VIVO Weill Cornell Medical College

Neurology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)